PepGen’s muscle disease program posts poor mid-stage results as one patient's data get markedly worse
PepGen’s muscle disease program posts poor mid-stage results as one patient's data get markedly worse
PepGen’s muscle disease program posts poor mid-stage results as one patient's data get markedly worse
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.